1: Gonçalves de Lima L, Rossi de Campos D. Development of a level A in vitro-in 
vivo correlation for extended release dosage forms of quetiapine fumarate. Drug 
Res (Stuttg). 2015 Dec 23. [Epub ahead of print] PubMed PMID: 26697891.

2: Upadhyay P, Trivedi J, Pundarikakshudu K, Sheth N. Comparative study between 
simple and optimized liposomal dispersion of quetiapine fumarate for diffusion 
through nasal route. Drug Deliv. 2015 Dec 8:1-8. [Epub ahead of print] PubMed 
PMID: 26643946.

3: Kalyankar P, Panzade P, Lahoti S. Formulation Design and Optimization of 
Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method. Indian J 
Pharm Sci. 2015 May-Jun;77(3):267-73. PubMed PMID: 26180271; PubMed Central 
PMCID: PMC4502140.

4: Bauer M, Thase ME, Liu S, Earley W, Eriksson H. Analysis of potentially 
predictive factors of efficacy of adjunct extended-release quetiapine fumarate in 
patients with major depressive disorder. J Psychopharmacol. 2015 
May;29(5):565-74. doi: 10.1177/0269881114552715. Epub 2014 Sep 25. PubMed PMID: 
25257148.

5: Kulinowski P, Woyna-Orlewicz K, Rappen GM, Haznar-Garbacz D, Węglarz WP, 
Dorożyński PP. An understanding of modified release matrix tablets behavior 
during drug dissolution as the key for prediction of pharmaceutical product 
performance - case study of multimodal characterization of quetiapine fumarate 
tablets. Int J Pharm. 2015 Apr 30;484(1-2):235-45. doi: 
10.1016/j.ijpharm.2015.02.040. Epub 2015 Feb 18. PubMed PMID: 25701626.

6: Li JC, Zhang WJ, Zhu JX, Zhu N, Zhang HM, Wang X, Zhang J, Wang QQ. 
Preparation and brain delivery of nasal solid lipid nanoparticles of quetiapine 
fumarate in situ gel in rat model of schizophrenia. Int J Clin Exp Med. 2015 Oct 
15;8(10):17590-600. eCollection 2015. PubMed PMID: 26770349; PubMed Central 
PMCID: PMC4694249.

7: Bonafede M, Locklear JC, Wahlqvist P, Fajutrao L, Szamosi J, Pan K, Eriksson 
H. Impact of once-daily extended-release quetiapine fumarate on hospitalization 
length in patients with acute bipolar mania. J Comp Eff Res. 2015 Jan;4(1):51-9. 
doi: 10.2217/cer.14.48. PubMed PMID: 25168473.

8: Kasper S, Montagnani G, Trespi G, Di Fiorino M. Treatment of depressive 
symptoms in patients with schizophrenia: a randomized, open-label, 
parallel-group, flexible-dose subgroup analysis of patients treated with 
extended-release quetiapine fumarate or risperidone. Int Clin Psychopharmacol. 
2015 Jan;30(1):14-22. doi: 10.1097/YIC.0000000000000053. PubMed PMID: 25356632.

9: Montgomery SA, Locklear JC, Svedsäter H, Eriksson H. Efficacy of once-daily 
extended release quetiapine fumarate in patients with different levels of 
severity of generalized anxiety disorder. Int Clin Psychopharmacol. 2014 
Sep;29(5):252-62. doi: 10.1097/YIC.0000000000000026. PubMed PMID: 24394383.

10: Locklear JC, Wahlqvist P, Gustafsson U, Udd M, Fajutrao L, Eriksson H. Impact 
of extended-release quetiapine fumarate on hospitalization length and cost in 
schizophrenia and bipolar disorder patients: a retrospective, hospital-based, 
US-cohort analysis. J Comp Eff Res. 2014 Jul;3(4):335-44. doi: 10.2217/cer.14.27. 
PubMed PMID: 25275231.

11: Findling RL, Pathak S, Earley WR, Liu S, DelBello MP. Efficacy and safety of 
extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, 
double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2014 
Aug;24(6):325-35. doi: 10.1089/cap.2013.0105. Epub 2014 Jun 23. PubMed PMID: 
24956042; PubMed Central PMCID: PMC4137347.

12: Li Q, Su YA, Liu Y, Chen JX, Tan YL, Yang FD, Si TM. Pharmacokinetics and 
tolerability of extended-release quetiapine fumarate in Han Chinese patients with 
schizophrenia. Clin Pharmacokinet. 2014 May;53(5):455-65. doi: 
10.1007/s40262-013-0127-9. PubMed PMID: 24385309.

13: Weisler R, Montgomery SA, Earley WR, Szamosi J, Eriksson H. Extended release 
quetiapine fumarate in patients with major depressive disorder: suicidality data 
from acute and maintenance studies. J Clin Psychiatry. 2014 May;75(5):520-7. doi: 
10.4088/JCP.13m08624. PubMed PMID: 24816198.

14: Di Fiorino M, Montagnani G, Trespi G, Kasper S. Extended-release quetiapine 
fumarate (quetiapine XR) versus risperidone in the treatment of depressive 
symptoms in patients with schizoaffective disorder or schizophrenia: a 
randomized, open-label, parallel-group, flexible-dose study. Int Clin 
Psychopharmacol. 2014 May;29(3):166-76. doi: 10.1097/YIC.0000000000000017. PubMed 
PMID: 24681810.

15: Montgomery SA, Altamura AC, Katila H, Datto C, Szamosi J, Eriksson H. 
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients 
with major depressive disorder: secondary analyses in subgroups of patients 
according to baseline anxiety, sleep disturbance, and pain levels. Int Clin 
Psychopharmacol. 2014 Mar;29(2):93-105. doi: 10.1097/YIC.0000000000000007. PubMed 
PMID: 24162081.

16: Clayton AH, Locklear JC, Svedsäter H, McIntyre RS. Sexual functioning in 
patients with major depressive disorder in randomized placebo-controlled studies 
of extended release quetiapine fumarate. CNS Spectr. 2014 Apr;19(2):182-96. doi: 
10.1017/S1092852913000631. Epub 2013 Sep 25. PubMed PMID: 24067192.

17: McIntyre A, Paisley D, Kouassi E, Gendron A. Quetiapine fumarate 
extended-release for the treatment of major depression with comorbid fibromyalgia 
syndrome: a double-blind, randomized, placebo-controlled study. Arthritis 
Rheumatol. 2014 Feb;66(2):451-61. doi: 10.1002/art.38228. PubMed PMID: 24504819.

18: Wang G, McIntyre A, Earley WR, Raines SR, Eriksson H. A randomized, 
double-blind study of the efficacy and tolerability of extended-release 
quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive 
disorder. Neuropsychiatr Dis Treat. 2014 Jan 30;10:201-16. doi: 
10.2147/NDT.S50248. eCollection 2014. PubMed PMID: 24511235; PubMed Central 
PMCID: PMC3916085.

19: Khan A, Atkinson S, Mezhebovsky I, She F, Leathers T, Pathak S. 
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in 
patients with generalized anxiety disorder and a history of inadequate treatment 
response: a randomized, double-blind study. Ann Clin Psychiatry. 2014 
Feb;26(1):3-18. PubMed PMID: 24660224.

20: Bandelow B, Bauer M, Vieta E, El-Khalili N, Gustafsson U, Earley WR, Eriksson 
H. Extended release quetiapine fumarate as adjunct to antidepressant therapy in 
patients with major depressive disorder: pooled analyses of data in patients with 
anxious depression versus low levels of anxiety at baseline. World J Biol 
Psychiatry. 2014 Feb;15(2):155-66. doi: 10.3109/15622975.2013.842654. PubMed 
PMID: 24506289.